Search results for: Bryan A. Liang

Items from 1 to 20 out of 57 results

article

In Reply—Electronic Health Records and Drugs Prescribed for Off-label Indications

Tim K. Mackey, Bryan A. Liang

Mayo Clinic Proceedings > 2017 > 92 > 4 > 684-685

article

After Amarin v FDA: What Will the Future Hold for Off-label Promotion Regulation?

Tim K. Mackey, Bryan A. Liang

Mayo Clinic Proceedings > 2016 > 91 > 6 > 701-706

article

Illicit Internet availability of drugs subject to recall and patient safety consequences

Tim K. Mackey, Phyo Aung, Bryan A. Liang

International Journal of Clinical Pharmacy > 2015 > 37 > 6 > 1076-1085

Background Permanently recalled drugs are a public health concern if they remain accessible in violation of applicable regulation. Illicit online pharmacies act as an alternative form of access and have been associated with the sale to patients of counterfeit/falsified/fraudulent/substandard drugs. We wished to determine if permanently recalled and significantly restricted drugs were illegally marketed...

article

The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications

Tim K. Mackey, Raphael E. Cuomo, Bryan A. Liang

BMC Health Services Research > 2015 > 15 > 1 > 1-9

Background Pharmaceutical marketing is undergoing a major shift in the United States, in part due to new transparency regulations under the healthcare reform act. Changes in pharmaceutical marketing practices include a possible shift from more traditional forms of direct-to-consumer advertising towards emerging use of Internet-based DTCA (“eDTCA”) given the growing importance of digital health or...

article

Prescription drug coupons: Evolution and need for regulation in direct-to-consumer advertising

Tim K. Mackey, Nozomi Yagi, Bryan A. Liang

Research in Social and Administrative Pharmacy > 2014 > 10 > 3 > 588-594

Pharmaceutical marketing in the United States had undergone a shift from largely exclusively targeting physicians to considerable efforts in targeting patients through various forms of direct-to-consumer advertising (“DTCA”). This includes the use of DTCA in prescription drug coupons (“PDCs”), a new form of DTCA that offers discounts and rebates directly to consumers to lower costs of drug purchasing...

article

The Minamata Convention on Mercury: Attempting to address the global controversy of dental amalgam use and mercury waste disposal

Tim K. Mackey, John T. Contreras, Bryan A. Liang

Science of the Total Environment > 2014 > 472 > Complete > 125-129

In October 2013, a new international binding treaty instrument called the Minamata Convention on Mercury opened for signature in Minamata City, Japan, the site of arguably the worst public health and environmental disaster involving mercury contamination. The treaty aims to curb the significant health and environmental impacts of mercury pollution and includes provisions addressing the mining, export...

article

Policy Review: Japan–Philippines Economic Partnership Agreement (JPEPA)—Analysis of a failed nurse migration policy

Nozomi Yagi, Tim K. Mackey, Bryan A. Liang, Lorna Gerlt

International Journal of Nursing Studies > 2014 > 51 > 2 > 243-250

In 2008, the bilateral Japan–Philippines Economic Partnership Agreement took effect. Contained within this regional free trade agreement are unique provisions allowing exchange of Filipino nurses and healthcare workers to work abroad in Japan. Japan's increasing need for healthcare workers due to its aging demographic and the Philippines need for economic development could have led to shared benefits...

article

An addiction to unsafe injection medication practices?

Bryan A. Liang

Journal of Clinical Anesthesia > 2013 > 25 > 7 > 519-520

article

Ensuring the future of health information online

Tim K Mackey, Bryan A Liang, Amir Attaran, Jillian C Kohler

The Lancet > 2013 > 382 > 9902 > 1404

article

Reply to Stanback et al.'s “Suspect Online Sellers and Contraceptive Access”

Bryan A. Liang, Timothy K. Mackey, Kimberly M. Lovett

Contraception > 2013 > 88 > 4 > 583

article

Illegal “No Prescription” Internet Access to Narrow Therapeutic Index Drugs

Bryan A. Liang, Tim K. Mackey, Kimberly M. Lovett

Clinical Therapeutics > 2013 > 35 > 5 > 694-700

Narrow therapeutic index (NTI) drugs, because of proximity of therapeutic amounts to toxic amounts, require close professional oversight, particularly when switching formulations. However, safe use may be compromised by unsupervised switching through access to online “no prescription” Web sites. We assessed no prescription online availability of NTI drugs, using an academically published list (core...

article

A United Nations Global Health Panel for Global Health Governance

Tim K. Mackey, Bryan A. Liang

Social Science & Medicine > 2013 > 76 > Complete > 12-15

The World Health Organization now relies upon voluntary contributions tied to specific projects, underwriting 75% of operations. A resulting cacophony of non-governmental, foundation, and private sector actors have emerged overlapping and fractionating WHO programs. In this expanding world of “global health organizations,” WHO's role must be redefined. We propose coordination of global health initiatives...

article

Response to comments on “A United Nations Global Health Panel for Global Health Governance”

Tim K. Mackey, Bryan A. Liang

Social Science & Medicine > 2013 > 76 > Complete > 24-27

article

Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health

Tim K Mackey, Bryan A Liang

Globalization and Health > 2013 > 9 > 1 > 1-12

Background Digital forms of direct-to-consumer pharmaceutical marketing (eDTCA) have globalized in an era of free and open information exchange. Yet, the unregulated expansion of eDTCA has resulted in unaddressed global public health threats. Specifically, illicit online pharmacies are engaged in the sale of purportedly safe, legitimate product that may in fact be counterfeit or substandard. These...

article

Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property

Tim K. Mackey, Bryan A. Liang

Drug Discovery Today > 2012 > 17 > 23-24 > 1254-1257

The appropriate role of innovation and intellectual property (IP) in global public health is a controversial issue. Discussion is one-sided, with potential benefits advocated by industry in stark contrast to condemnation by certain civil society players. WHO's Public Health, Innovation and Intellectual Property Department (PHI) was established to address healthcare resource need for developing countries,...

article

Suspect online sellers and contraceptive access

Bryan A. Liang, Tim K. Mackey, Kimberly M. Lovett

Contraception > 2012 > 86 > 5 > 551-556

Issues surrounding contraception access have been a national focus. During this debate, adolescent and adult women may seek these products online. Due to safety concerns, including potential counterfeit forms, we wished to assess whether online “no prescription” contraceptives were available.We assessed online availability of reversible, prescription contraceptive methods resulting in <10 undesired...

article

Separating online piracy from counterfeit medicines: The need for policy reform and a call to action

Tim Ken Mackey, Bryan A. Liang

Health Policy and Technology > 2012 > 1 > 3 > 120-122

The recent public backlash against proposed federal anti-piracy legislation provides important lessons regarding promoting public policy for public health and patient safety online. Anti-piracy legislation contained many novel regulatory strategies that may have had an impact on combating counterfeit medicines sold by online pharmacies, but was derailed due to non-health related considerations and...

article

Global health policy coordination to address neglected tropical diseases

Tim K. Mackey, Bryan A. Liang

Tropical Medicine & International Health > 17 > 9 > 1053 - 1056

article

Elder Abuse

Bryan A. Liang, Kimberly M. Lovett, Timothy K. Mackey

Journal of the American Geriatrics Society > 60 > 2 > 398 - 400

article

Vaccine shortages and suspect online pharmacy sellers

Bryan A. Liang, Tim K. Mackey

Vaccine > 2012 > 30 > 2 > 105-108

Vaccines represent half the products on the FDA Biologics Product Shortages list. As a result, providers and patients may purchase them online, a process rife with patient safety risks. We examined vaccine online availability by assessing up to 5 identified online sellers. We determined if sites were accredited by the National Association of Boards of Pharmacy (NABP) VIPPS program, listed as US or...

Publication date

Set your own date range

INFONA - science communication portal

Search results for: Bryan A. Liang

In Reply—Electronic Health Records and Drugs Prescribed for Off-label Indications

After Amarin v FDA: What Will the Future Hold for Off-label Promotion Regulation?

Illicit Internet availability of drugs subject to recall and patient safety consequences

The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications

Prescription drug coupons: Evolution and need for regulation in direct-to-consumer advertising

The Minamata Convention on Mercury: Attempting to address the global controversy of dental amalgam use and mercury waste disposal

Policy Review: Japan–Philippines Economic Partnership Agreement (JPEPA)—Analysis of a failed nurse migration policy

An addiction to unsafe injection medication practices?

Ensuring the future of health information online

Reply to Stanback et al.'s “Suspect Online Sellers and Contraceptive Access”

Illegal “No Prescription” Internet Access to Narrow Therapeutic Index Drugs

A United Nations Global Health Panel for Global Health Governance

Response to comments on “A United Nations Global Health Panel for Global Health Governance”

Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health

Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property

Suspect online sellers and contraceptive access

Separating online piracy from counterfeit medicines: The need for policy reform and a call to action

Global health policy coordination to address neglected tropical diseases

Elder Abuse

Vaccine shortages and suspect online pharmacy sellers

Filter options

Publication date

Content availability

Keywords

Data set

Journal

INFONA - science communication portal

Search results for: Bryan A. Liang

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Content availability

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options